MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

0.7327 +0.0123 (+1.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,230
Open 0.7200
Bid (Size) 0.7012 (1,300)
Ask (Size) 0.7359 (200)
Prev. Close 0.7204
Today's Range 0.7200 - 0.7359
52wk Range 0.5011 - 2.186
Shares Outstanding 39,388,443
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TELA Bio to Announce Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Issued on behalf of Conexeu Sciences Inc. 
From Biotech Insider
Via GlobeNewswire

Performance

YTD
-35.7%
-35.7%
1 Month
-9.0%
-9.0%
3 Month
+18.2%
+18.2%
6 Month
-21.4%
-21.4%
1 Year
-63.0%
-63.0%

More News

Read More
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance ↗
Via Chartmill
News headline image
TELA Bio Reports First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates ↗
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Analysts Cut Their Forecasts After Q4 Results ↗
Via Benzinga
News headline image
TELA Bio (TELA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings ↗
Via Benzinga
News headline image
TELA Bio Inc (NASDAQ:TELA) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
Via Chartmill
News headline image
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
From TELA Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is TELA Bio, Inc. - Common stock publicly traded?
Yes, TELA Bio, Inc. - Common stock is publicly traded.
What exchange does TELA Bio, Inc. - Common stock trade on?
TELA Bio, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for TELA Bio, Inc. - Common stock?
The ticker symbol for TELA Bio, Inc. - Common stock is TELA on the Nasdaq Stock Market
What is the current price of TELA Bio, Inc. - Common stock?
The current price of TELA Bio, Inc. - Common stock is 0.7327
When was TELA Bio, Inc. - Common stock last traded?
The last trade of TELA Bio, Inc. - Common stock was at 07/22/26 04:00 PM ET
What is the market capitalization of TELA Bio, Inc. - Common stock?
The market capitalization of TELA Bio, Inc. - Common stock is 28.86M
How many shares of TELA Bio, Inc. - Common stock are outstanding?
TELA Bio, Inc. - Common stock has 29M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story